These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 34256029
1. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States. Hosier H, Sheth SS, Oliveira CR, Perley LE, Vash-Margita A. Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029 [Abstract] [Full Text] [Related]
7. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania. Şuteu O, Blaga ML, Nygård M, Leinonen MK, Nicula F, Păiş R, Coza D, Cadariu PA, Melnic A, Andreassen T, Hashim D, Weiderpass E. Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568 [Abstract] [Full Text] [Related]
9. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer. Song T, Seong SJ, Lee SK, Kim BR, Ju W, Kim KH, Nam K, Sim JC, Kim TJ. J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702 [Abstract] [Full Text] [Related]
11. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial. Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. JAMA; 2018 Jul 03; 320(1):43-52. PubMed ID: 29971397 [Abstract] [Full Text] [Related]
13. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]. Ronco G, Confortini M, Maccallini V, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Giorgi Rossi P. Epidemiol Prev; 2012 Jul 03; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163 [Abstract] [Full Text] [Related]
14. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. CA Cancer J Clin; 2020 Sep 03; 70(5):321-346. PubMed ID: 32729638 [Abstract] [Full Text] [Related]
16. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women. Zhao X, Wu Q, Wang X, Fu Y, Zhang X, Tian X, Cheng B, Lu B, Yu X, Lan S, Lu W, Ma D, Cheng X, Xie X. Clin Microbiol Infect; 2018 Dec 03; 24(12):1322-1327. PubMed ID: 29518562 [Abstract] [Full Text] [Related]
17. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force. Kim JJ, Burger EA, Regan C, Sy S. JAMA; 2018 Aug 21; 320(7):706-714. PubMed ID: 30140882 [Abstract] [Full Text] [Related]
18. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females. Hirth JM, Lin YL, Kuo YF, Berenson AB. Prev Med; 2016 Jul 21; 88():134-9. PubMed ID: 27085993 [Abstract] [Full Text] [Related]